Chalasani Sai, Mannam Harshita, Alomari Ahmed K, Rahnama-Moghadam Sahand
Dermatology, Indiana University School of Medicine, Indianapolis, USA.
Dermatology/Pathology, Indiana University School of Medicine, Indianapolis, USA.
Cureus. 2025 Jan 3;17(1):e76860. doi: 10.7759/cureus.76860. eCollection 2025 Jan.
Drug reaction with eosinophilia and systemic symptoms (DRESS) is a severe cutaneous adverse drug reaction mediated by a complex immune response. Vancomycin is a known cause of DRESS, and cases are often attributed to intravenous exposure. Vancomycin-laden bone cements deliver high concentrations of the drug locally with low to undetectable systemic levels. Despite trace systemic concentrations, cement spacers have been reported to cause systemic reactions ranging from organ failure to diffuse cutaneous eruptions. A patient receiving intravenous (IV) and local vancomycin, via bone cement, experienced symptom resolution only after the vancomycin-eluting bone cement was removed, which was done after the IV vancomycin had been stopped. This suggests that the vancomycin eluted from the local bone cement may be sufficient to maintain the immune response mediating DRESS syndrome. In patients who experience persistent symptoms despite discontinuing systemic drug exposure, clinicians should consider eliminating all sources of the causative drug.
药物超敏反应伴嗜酸性粒细胞增多和全身症状(DRESS)是一种由复杂免疫反应介导的严重皮肤药物不良反应。万古霉素是已知的导致DRESS的原因,病例通常归因于静脉暴露。负载万古霉素的骨水泥在局部递送高浓度药物,全身水平低至无法检测。尽管全身浓度微量,但据报道骨水泥间隔物会引起从器官衰竭到弥漫性皮肤疹的全身反应。一名通过骨水泥接受静脉注射(IV)和局部万古霉素治疗的患者,仅在停用静脉万古霉素后取出万古霉素洗脱骨水泥后症状才得到缓解。这表明从局部骨水泥中洗脱的万古霉素可能足以维持介导DRESS综合征的免疫反应。对于尽管停止全身药物暴露仍有持续症状的患者,临床医生应考虑消除致病药物的所有来源。